What the FDA’s New GLP-1 Warning Means for Patients at Risk of Vision Loss

GLP-1 medications have become widely used to manage type 2 diabetes and support long-term weight management. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have helped many patients manage chronic health conditions. However, a new safety announcement from the U.S. Food and Drug Administration (FDA) has raised concerns about a rare but potentially serious eye condition associated with this class of medications.

GLP-1 medications have become widely used to manage type 2 diabetes and support long-term weight management. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have helped many patients manage chronic health conditions. However, a new safety announcement from the U.S. Food and Drug Administration (FDA) has raised concerns about a rare but potentially serious eye…

Read More